{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T23:10:06Z","timestamp":1755817806231,"version":"3.44.0"},"reference-count":34,"publisher":"Georg Thieme Verlag KG","issue":"03","license":[{"start":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T00:00:00Z","timestamp":1745193600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Asian J Neurosurg"],"published-print":{"date-parts":[[2025,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>High-grade gliomas (HGGs) have dismal prognosis even with multimodality treatment entailing surgery, radiotherapy, and chemotherapy. Hence, assessment of improvement in quality of life (QOL) for evaluating treatment is critical. Target delineation for radiotherapy in HGG is often done according to the European Organization for Research and Treatment of Cancer (EORTC) and Radiotherapy and Oncology Group (RTOG) contouring guidelines, which differs on exclusion and inclusion of peritumoral edema believed to harbor malignant cells; the guidelines have not been prospectively compared for probable difference in QOL, considering the probable difference in treated volume.<\/jats:p><jats:p>This article compares QOL in HGG patients receiving postoperative radiotherapy using target volume delineation based on the RTOG or EORTC guidelines.<\/jats:p><jats:p>In this single-center, prospective randomized exploratory study, postoperative HGG patients were randomized to either receive radiotherapy according to the EORTC guidelines of target delineation (60 Gy\/30 fractions to tumor bed and residual tumor) or the RTOG guidelines (46 Gy\/23fractions to tumor bed, residual tumor, and peritumoral edema with 14 Gy\/7 fraction boost to the tumor bed and residual tumor) with concurrent temozolomide (TMZ) followed by 6 months of adjuvant TMZ. The aim and primary endpoint of the study was to assess and compare QOL between the arms. Descriptive statistics were used to convey demographic data, proportions for categorical variables, and mean, median, range, and standard deviation for continuous variables. Effect size was assessed using partial eta squared test where values of 0.01, 0.06, and 0.14 signify small, medium, and large effect size, respectively. Repeated measures analysis of variance test was used for comparison of means and assessment of QOL between the EORTC and RTOG groups at 6 months. Absolute volume of planning target volume (PTV) receiving 46 and 60 Gy were described, PTV 46\/60 was also described in terms of % of whole brain volume.<\/jats:p><jats:p>Eighteen patients underwent randomization (9 in EORTC and RTOG group each). Statistically significant improvement was noted in the overall posttreatment values in the physical well-being (PWB) domain (p\u2009=\u20090.007).<\/jats:p><jats:p>This is the first study to compare the EORTC and RTOG delineation techniques in terms of QOL. No significant differences in QOL were noted between the two arms. Significant improvement was noted posttreatment in PWB of overall patients.<\/jats:p>","DOI":"10.1055\/s-0045-1807761","type":"journal-article","created":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T18:55:39Z","timestamp":1745261739000},"page":"506-513","source":"Crossref","is-referenced-by-count":0,"title":["Comparison of Quality of Life in Postoperative High-Grade Glioma Patients Treated Using EORTC and RTOG Target Delineation Techniques for Postoperative Radiotherapy"],"prefix":"10.1055","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2458-7590","authenticated-orcid":false,"given":"Shreyosi","family":"Mandal","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India"},{"name":"Department of Radiation Oncology, Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deepa","family":"Joseph","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ajay","family":"Krishnan","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India"},{"name":"Department of Radiation Oncology, Tata Memorial Centre, Homi Bhabha Cancer Hospital and Mahamana Pandit Madan Mohan Malviya Cancer Centre, Varanasi, Uttar Pradesh, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pragya","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India"},{"name":"Royal Surrey Hospital NHS Foundation Trust, Guilford, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajnish Kumar","family":"Arora","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Udit","family":"Chauhan","sequence":"additional","affiliation":[{"name":"Department of Radiology, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3893-2781","authenticated-orcid":false,"given":"Sweety","family":"Gupta","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lekshmi","family":"R.","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manoj","family":"Gupta","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2025,4,21]]},"reference":[{"issue":"01","key":"ref2","first-page":"29","article-title":"Survival trends of grade I, II, and III astrocytoma patients and associated clinical practice patterns between 1999 and 2010: a SEER-based analysis","volume":"3","author":"X Dong","year":"2016","journal-title":"Neurooncol Pract"},{"issue":"01","key":"ref3","doi-asserted-by":"crossref","first-page":"20162","DOI":"10.1038\/s41598-020-77228-2","article-title":"Survival outcome and prognostic factors in anaplastic oligodendroglioma: a single-institution study of 95 cases","volume":"10","author":"D W Shin","year":"2020","journal-title":"Sci Rep"},{"issue":"04","key":"ref4","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1002\/1097-0142(19810215)47:4<649::AID-CNCR2820470405>3.0.CO;2-W","article-title":"Combined modality therapy of operated astrocytomas grade III and IV. Confirmation of the value of postoperative irradiation and lack of potentiation of bleomycin on survival time: a prospective multicenter trial of the Scandinavian Glioblastoma Study Group","volume":"47","author":"K Kristiansen","year":"1981","journal-title":"Cancer"},{"issue":"01","key":"ref5","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.radonc.2015.12.003","article-title":"ESTRO-ACROP guideline \u201ctarget delineation of glioblastomas.\u201d","volume":"118","author":"M Niyazi","year":"2016","journal-title":"Radiother Oncol"},{"issue":"03","key":"ref6","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3171\/jns.1978.49.3.0333","article-title":"Evaluation of BCNU and\/or radiotherapy in the treatment of anaplastic gliomas: a cooperative clinical trial","volume":"49","author":"M D Walker","year":"1978","journal-title":"J Neurosurg"},{"issue":"07","key":"ref7","first-page":"95","article-title":"Beyond the World Health Organization grading of infiltrating gliomas: advances in the molecular genetics of glioma classification","volume":"3","author":"K Vigneswaran","year":"2015","journal-title":"Ann Transl Med"},{"issue":"01","key":"ref8","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3174\/ajnr.A2743","article-title":"Correlations between perfusion MR imaging cerebral blood volume, microvessel quantification, and clinical outcome using stereotactic analysis in recurrent high-grade glioma","volume":"33","author":"L S Hu","year":"2012","journal-title":"AJNR Am J Neuroradiol"},{"issue":"02","key":"ref9","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.nec.2012.01.003","article-title":"Radiation options for high-grade gliomas","volume":"23","author":"B B Taw","year":"2012","journal-title":"Neurosurg Clin N Am"},{"issue":"04","key":"ref10","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.7150\/jca.51107","article-title":"Advances in radiotherapy and comprehensive treatment of high-grade glioma: immunotherapy and tumor-treating fields","volume":"12","author":"S Liu","year":"2021","journal-title":"J Cancer"},{"issue":"02","key":"ref11","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0167-8140(92)90018-P","article-title":"A quantitative assessment of the addition of MRI to CT-based, 3-D treatment planning of brain tumors","volume":"25","author":"R K Ten Haken","year":"1992","journal-title":"Radiother Oncol"},{"issue":"10","key":"ref12","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"R Stupp","year":"2005","journal-title":"N Engl J Med"},{"issue":"02","key":"ref13","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3171\/jns.1983.58.2.0159","article-title":"Computerized tomographic and pathologic studies of the untreated, quiescent, and recurrent glioblastoma multiforme","volume":"58","author":"P C Burger","year":"1983","journal-title":"J Neurosurg"},{"issue":"06","key":"ref14","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/0360-3016(89)90548-8","article-title":"Radiation therapy treatment planning in supratentorial glioblastoma multiforme: an analysis based on post mortem topographic anatomy with CT correlations","volume":"17","author":"E C Halperin","year":"1989","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"06","key":"ref15","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/0360-3016(89)90941-3","article-title":"Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma","volume":"16","author":"K E Wallner","year":"1989","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"04","key":"ref16","doi-asserted-by":"crossref","first-page":"559","DOI":"10.3171\/jns.1991.75.4.0559","article-title":"Malignant astrocytomas: focal tumor recurrence after focal external beam radiation therapy","volume":"75","author":"B C Liang","year":"1991","journal-title":"J Neurosurg"},{"issue":"01","key":"ref17","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.ijrobp.2006.12.009","article-title":"Evaluation of peritumoral edema in the delineation of radiotherapy clinical target volumes for glioblastoma","volume":"68","author":"E L Chang","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"03","key":"ref18","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.radonc.2010.08.020","article-title":"Patterns of failure and comparison of different target volume delineations in patients with glioblastoma treated with conformal radiotherapy plus concomitant and adjuvant temozolomide","volume":"97","author":"G Minniti","year":"2010","journal-title":"Radiother Oncol"},{"issue":"08","key":"ref19","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJMoa1308573","article-title":"A randomized trial of bevacizumab for newly diagnosed glioblastoma","volume":"370","author":"M R Gilbert","year":"2014","journal-title":"N Engl J Med"},{"issue":"01","key":"ref20","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.prro.2018.06.001","article-title":"Using smaller-than-standard radiation treatment margins does not change survival outcomes in patients with high-grade gliomas","volume":"9","author":"K Guram","year":"2019","journal-title":"Pract Radiat Oncol"},{"issue":"02","key":"ref21","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/COC.0b013e318271ae03","article-title":"Limited margins using modern radiotherapy techniques does not increase marginal failure rate of glioblastoma","volume":"37","author":"A K Paulsson","year":"2014","journal-title":"Am J Clin Oncol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.ijrobp.2009.07.1754","article-title":"Use of normal tissue complication probability models in the clinic","volume":"76","author":"L B Marks","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"09","key":"ref23","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1212\/WNL.30.9.907","article-title":"Assumptions in the radiotherapy of glioblastoma","volume":"30","author":"F H Hochberg","year":"1980","journal-title":"Neurology"},{"issue":"01","key":"ref24","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1215\/15228517-2008-050","article-title":"Health-related quality of life in patients with high-grade glioma","volume":"11","author":"J X Cheng","year":"2009","journal-title":"Neuro-oncol"},{"issue":"32","key":"ref25","doi-asserted-by":"crossref","first-page":"4085","DOI":"10.1200\/JCO.2013.49.6968","article-title":"Dose-dense temozolomide for newly diagnosed glioblastoma: a randomized phase III clinical trial","volume":"31","author":"M R Gilbert","year":"2013","journal-title":"J Clin Oncol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1053\/sonc.2002.33535","article-title":"Advances in quality of life measurements in oncology patients","volume":"29","author":"D Cella","year":"2002","journal-title":"Semin Oncol"},{"issue":"02","key":"ref27","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s11060-013-1299-8","article-title":"Quality of life research in neuro-oncology: a quantitative comparison","volume":"116","author":"E Klein","year":"2014","journal-title":"J Neurooncol"},{"issue":"05","key":"ref28","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/1097-0142(19950301)75:5<1151::AID-CNCR2820750515>3.0.CO;2-Q","article-title":"The Functional Assessment of Cancer Therapy (FACT) scale: development of a brain subscale and revalidation of the general version (FACT-G) in patients with primary brain tumors","volume":"75","author":"M A Weitzner","year":"1995","journal-title":"Cancer"},{"issue":"01","key":"ref29","doi-asserted-by":"crossref","first-page":"40","DOI":"10.5732\/cjc.013.10214","article-title":"Health-related quality of life in high-grade glioma patients","volume":"33","author":"L Dirven","year":"2014","journal-title":"Chin J Cancer"},{"issue":"03","key":"ref30","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s11060-021-03920-6","article-title":"Quality of life following concurrent temozolomide-based chemoradiation therapy or observation in low-grade glioma","volume":"156","author":"D Y Park","year":"2022","journal-title":"J Neurooncol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"e465","DOI":"10.1016\/j.wneu.2018.06.052","article-title":"Perioperative and postoperative quality of life in patients with glioma\u2013a longitudinal cohort study","volume":"117","author":"C Drewes","year":"2018","journal-title":"World Neurosurg"},{"issue":"01","key":"ref32","first-page":"86","article-title":"Impact of volume of irradiation on survival and quality of life in glioblastoma: a prospective, phase 2, randomized comparison of RTOG and MDACC protocols","volume":"7","author":"N Kumar","year":"2020","journal-title":"Neurooncol Pract"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1108587","DOI":"10.3389\/fonc.2023.1108587","article-title":"Comparative dosimetric study of radiotherapy in high-grade gliomas based on the guidelines of EORTC and NRG-2019 target delineation","volume":"13","author":"O Yan","year":"2023","journal-title":"Front Oncol"},{"issue":"01","key":"ref34","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1080\/02688697.2019.1698011","article-title":"Does preoperative health-related quality of life predict survival in high-grade glioma patients? - a prospective study","volume":"34","author":"L M Haraldseide","year":"2020","journal-title":"Br J Neurosurg"},{"issue":"02","key":"ref35","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.3892\/ol.2017.6310","article-title":"Analysis of health-related quality of life in patients with brain tumors prior and subsequent to radiotherapy","volume":"14","author":"C Bitterlich","year":"2017","journal-title":"Oncol Lett"}],"container-title":["Asian Journal of Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0045-1807761.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T22:41:46Z","timestamp":1755816106000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-0045-1807761"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,21]]},"references-count":34,"journal-issue":{"issue":"03","published-online":{"date-parts":[[2025,8,21]]},"published-print":{"date-parts":[[2025,9]]}},"URL":"https:\/\/doi.org\/10.1055\/s-0045-1807761","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["1793-5482","2248-9614"],"issn-type":[{"type":"print","value":"1793-5482"},{"type":"electronic","value":"2248-9614"}],"subject":[],"published":{"date-parts":[[2025,4,21]]}}}